CN1593599A - Ointment for dispersing breast nodules and preparation method thereof - Google Patents

Ointment for dispersing breast nodules and preparation method thereof Download PDF

Info

Publication number
CN1593599A
CN1593599A CN 200410043648 CN200410043648A CN1593599A CN 1593599 A CN1593599 A CN 1593599A CN 200410043648 CN200410043648 CN 200410043648 CN 200410043648 A CN200410043648 A CN 200410043648A CN 1593599 A CN1593599 A CN 1593599A
Authority
CN
China
Prior art keywords
rhizoma curcumae
semen
chinese medicine
angelicae dahuricae
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200410043648
Other languages
Chinese (zh)
Other versions
CN1251755C (en
Inventor
吴蓓莉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heilongjiang Hexiang Pharmaceutical Co ltd
Original Assignee
QIQIHAR HEXIANG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QIQIHAR HEXIANG PHARMACEUTICAL CO Ltd filed Critical QIQIHAR HEXIANG PHARMACEUTICAL CO Ltd
Priority to CN 200410043648 priority Critical patent/CN1251755C/en
Publication of CN1593599A publication Critical patent/CN1593599A/en
Application granted granted Critical
Publication of CN1251755C publication Critical patent/CN1251755C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a externally used plaster for treating galactophore diseases and method for its preparation, wherein the plaster is prepared from zedoary 153-187, curcuma longa 122-150, garden balsam seed 122-150, root of muskroot-like semiaqilegia 91.8-112.2, momordica seed 30.6-37.4, dahurian angelica root 45.9-56.1 through disintegrating into mesh fines, preparing alcohol extract grease, heating honey and stirring.

Description

Eliminating stagnation nodules of the breast plaster and preparation method thereof
Technical field:
The present invention relates to mastotic externally used paste of a kind of treatment and preparation method thereof.
Background technology:
There is the drawback that Chinese medicine ingredients is many, cost is high, curative effect is bad in the mastotic Chinese medicine of existing treatment, and there is the drawback of complex procedures in prior preparation method.
Summary of the invention:
The object of the present invention is to provide a kind of good effect, the simple eliminating stagnation nodules of the breast of preparation section plaster and preparation method thereof, the unguentum of eliminating stagnation nodules of the breast plaster comprises Rhizoma Curcumae, Rhizoma Curcumae Longae, Semen Impatientis, Radix Semiaquilegiae, Semen Momordicae, Radix Angelicae Dahuricae Six-element Chinese medicine, and the shared parts by weight of each Chinese medicine are respectively: Rhizoma Curcumae 153~187, Rhizoma Curcumae Longae 122~150, Semen Impatientis 122~150, Radix Semiaquilegiae 91.8~112.2, Semen Momordicae 30.6~37.4, the Radix Angelicae Dahuricae 45.9~56.1.Its preparation method comprises: a. gets Rhizoma Curcumae, curcuma powder is broken into fine powder, crosses 100 mesh sieves, warp 60Behind the Co irradiation, standby; B. after getting Semen Impatientis, Radix Semiaquilegiae, Semen Momordicae, Radix Angelicae Dahuricae four Chinese medicine material and being mixed in proportion, be 85% alcohol heating reflux extraction 2 times with accounting for four Chinese medicine gross weight 4 times of amounts, concentration respectively, return time was respectively 1 hour, filter then, it is 1.32 thick paste that merging filtrate, decompression recycling ethanol are concentrated into relative density in the time of 60 ℃, in dry below 60 ℃, be ground into fine powder, cross 100 mesh sieves, standby; Get Mel 1500g, heating dissolves, cross the 180 mesh sieve removal of impurity while hot, the fine powder that when 60, adds above-mentioned Rhizoma Curcumae and Rhizoma Curcumae Longae, stir, after adding the alcohol extraction cream powder of Semen Impatientis, Radix Semiaquilegiae, Semen Momordicae, the Radix Angelicae Dahuricae four flavor Chinese medicines and concentration again and be 3% laurocapram, stirred 20 minutes, mixing gets final product.
Eliminating stagnation nodules of the breast plaster of the present invention can be used for cystic hyperplasia of breast, this sick genus traditional Chinese medical science qi depression to blood stasis disease, and disease is seen lump in the breast, accompany mastalgia, mostly be distending pain, scurry pain or twinge, the costa sternales distension increases and decreases with menstrual cycle and emotion changes, dimly red tongue or ecchymosis is arranged, stringy pulse or string are puckery, and it has the effect of promoting flow of QI and blood, mass dissipating and swelling eliminating, and of the present invention have only Six-element Chinese medicine, not only cost is low for it, and good effect, preparation method is simple, is beneficial to apply.
The specific embodiment:
The specific embodiment one: the unguentum in the present embodiment comprises Rhizoma Curcumae, Rhizoma Curcumae Longae, Semen Impatientis, Radix Semiaquilegiae, Semen Momordicae, Radix Angelicae Dahuricae Six-element Chinese medicine, and the shared parts by weight of each Chinese medicine are respectively: Rhizoma Curcumae 153~187, Rhizoma Curcumae Longae 122~150, Semen Impatientis 122~150, Radix Semiaquilegiae 91.8~112.2, Semen Momordicae 30.6~37.4, the Radix Angelicae Dahuricae 45.9~56.1; Its preparation method is: a. gets Rhizoma Curcumae, curcuma powder is broken into fine powder, crosses 100 mesh sieves, warp 60Behind the Co irradiation, standby; B. after getting Semen Impatientis, Radix Semiaquilegiae, Semen Momordicae, Radix Angelicae Dahuricae four Chinese medicine material and being mixed in proportion, be 85% alcohol heating reflux extraction 2 times with accounting for four Chinese medicine gross weight 4 times of amounts, concentration respectively, return time was respectively 1 hour, filter then, it is 1.32 thick paste that merging filtrate, decompression recycling ethanol are concentrated into relative density in the time of 60 ℃, in dry below 60 ℃, be ground into fine powder, cross 100 mesh sieves, standby; Get Mel 1500g, heating dissolves, cross the 180 mesh sieve removal of impurity while hot, the fine powder that when 60, adds above-mentioned Rhizoma Curcumae and Rhizoma Curcumae Longae, stir, after adding the alcohol extraction cream powder of Semen Impatientis, Radix Semiaquilegiae, Semen Momordicae, the Radix Angelicae Dahuricae four flavor Chinese medicines and concentration again and be 3% laurocapram, stirred 20 minutes, mixing gets final product.
The specific embodiment two: the shared parts by weight of each Chinese medicine are respectively in the present embodiment, Rhizoma Curcumae 160, Rhizoma Curcumae Longae 125, Semen Impatientis 125, Radix Semiaquilegiae 95, Semen Momordicae 32, the Radix Angelicae Dahuricae 48.
The specific embodiment three: the shared parts by weight of each Chinese medicine are respectively in the present embodiment, Rhizoma Curcumae 170, Rhizoma Curcumae Longae 136, Semen Impatientis 136, Radix Semiaquilegiae 102, Semen Momordicae 34, the Radix Angelicae Dahuricae 51.
The specific embodiment four: the shared parts by weight of each Chinese medicine are respectively in the present embodiment, Rhizoma Curcumae 182, Rhizoma Curcumae Longae 145, Semen Impatientis 145, Radix Semiaquilegiae 108, Semen Momordicae 37, the Radix Angelicae Dahuricae 54.
The specific embodiment five: the preparation method of present embodiment is as follows: get 1700g Rhizoma Curcumae, 1360g Rhizoma Curcumae Longae, be ground into fine powder, cross 100 mesh sieves, warp 60Behind the Co irradiation, standby; After getting 1360g Semen Impatientis, 1020g Radix Semiaquilegiae, 340g Semen Momordicae, the mixing of 510g Radix Angelicae Dahuricae four Chinese medicine material, be 85% alcohol heating reflux extraction 2 times with accounting for four Chinese medicine gross weight 4 times of amounts, concentration respectively, return time was respectively 1 hour, filter, it is 1.32 thick paste that merging filtrate, decompression recycling ethanol are concentrated into relative density in the time of 60 ℃, in dry below 60 ℃, be ground into fine powder, cross 100 mesh sieves, standby; Get Mel 1500g, heating dissolves, cross the 180 mesh sieve removal of impurity while hot, the fine powder that when 60, adds above-mentioned Rhizoma Curcumae and Rhizoma Curcumae Longae, stir, after adding the alcohol extraction cream powder of Semen Impatientis, Radix Semiaquilegiae, Semen Momordicae, the Radix Angelicae Dahuricae four flavor Chinese medicines and concentration again and be 3% laurocapram, stirred mixing 20 minutes.The gained creme is with mould molding (4 * 6.5cm, heavy 5g), and behind all cotton non-woven fabric parcel, (on 7 * 10cm), seal with plastic bag, packing is made 1000 and pasted, promptly to place tensoplast.
Character: this product is pale brown color chips shape plaster, gas perfume (or spice).
The curative effect comprehensive report:
One. the case choice criteria:
1. meet the diagnostic criteria of doctor trained in Western medicine cyclomastopathy.
2. meet the dialectical standard of traditional Chinese medical science syndrome of qi stagnation and blood stasis.
3. the age was 18~55 years old women.
4. informed consent volunteers to be tried and sign the genus Informed Consent Form.
Two, the diagnostic criteria of disease:
1. Western medicine diagnose standard:
(1) mastalgia;
(2) lump in breast;
(3) auxiliary examination: 1. the mammary gland color doppler flow imaging 2. breast molybdenum target X line take the photograph 3. pathological examination of sheet.
2. Chinese medical discrimination standard:
Syndrome of qi stagnation and blood stasis: lump in breast, mastalgia, companion's costa sternales distension, susceptible to lose temper due to restlessness, the few color of menstrual blood volume is dark or clot, abdominal pain during menstruation arranged.Dimly red tongue or petechia, ecchymosis are arranged, white and thin fur, stringy pulse or string are puckery.
(1) primary symptom: lump in breast, mastalgia.
(2) inferior disease: 1. costa sternales distension; 2. susceptible to lose temper due to restlessness; 3. the few color of menstrual blood volume is dark or clot, abdominal pain during menstruation arranged.Tongue is dark red or petechia, ecchymosis, white and thin fur arranged.Pulse condition string or string are puckery.
Three. medicine ingredient: Rhizoma Curcumae, Rhizoma Curcumae Longae, Semen Impatientis, open certain herbaceous plants with big flowers, Semen Momordicae, the Radix Angelicae Dahuricae.
Four. administrated method: external.Earlier the skin affected part is cleaned and wiped away driedly, then lining paper on the plaster is thrown off, medicated core is aimed at the affected part stick.Once a day, each one pastes every subsides content of dispersion 5g.Sticked continuously 28 days.
Five. the criterion of curative effect:
1. clinical recovery: clinical symptoms, sign, lump in breast, mastalgia disappear.
2. produce effects: clinical symptoms, sign, mastalgia obviously alleviate or disappear, and the lump in breast major diameter dwindles more than 1/2.
3. effective: clinical symptoms, sign, mastalgia alleviate or disappear, and the lump in breast major diameter dwindles more than 1/3.
4. invalid: clinical symptoms, sign do not have change, and lump in breast is not seen to have and obviously dwindled or dwindle deficiency.
Six. the analysis of efficacy result, answer the coincidence statistics standard:
The typing of data is responsible for by the specific data manager of PLA General Hospital medical statistics teaching and research room with management.For guaranteeing the accuracy of data, should independently carry out double typing and check and correction by two data managers.
To the query that exists in the case report form, the data administrator will produce FAQ table (DRQ), and send inquiry to researcher by the CRA, researcher should answer and return as early as possible, the data administrator carries out data modification, affirmation and typing according to the answer of researcher, can send DRQ once more in case of necessity.
1. intentional analysis: all are divided into groups through randomization, and use whole cases of a medicine to analyze at least.Intentional analysis carries out at curative effect and adverse events.For the case data of failing to observe whole therapeutic processes, carry over the test final result to last observed data.
2. meet the scheme data analysis: all Pass Test schemes, medication more than 14 days, good, the duration of test of compliance do not use the case of forbidding medication, finishing CRF regulation fill substance, and its curative effect is carried out statistical analysis.
3. statistical analysis adopts SAS 6.12 statistical analysis softwares to calculate.
All statistical test all adopt two-sided test, and the P value is less than or equal to 0.05 difference that will be considered to be checked statistical significance.
The measurement data that each time prescription on individual diagnosis is organized in different treatments will adopt mean ± standard deviation to carry out descriptive statistics.Compare with screening phase basic value, adopt front and back difference in the paired t-test comparable group.The variation of two groups of treatment front and back is adopted variance analysis (ANOVA) row relatively.
The enumeration data that each time prescription on individual diagnosis is organized in different treatments adopts frequency (constituent ratio) to carry out descriptive statistics.X is adopted in the variation of two groups of treatment front and back 2Check or rank test.
Sequence number Age Sex Occupation Before the treatment After the treatment Curative effect
1 ?25 The woman The nurse Severe Recovery from illness Recovery from illness
2 ?25 The woman The workman Severe Slightly Produce effects
3 ?26 The woman The coroner Moderate Recovery from illness Effectively
4 ?26 The woman The doctor Severe Moderate Effectively
5 ?28 The woman The workman Severe Slightly Produce effects
6 ?28 The woman The peasant Slightly Recovery from illness Recovery from illness
7 ?28 The woman The civil servant Severe Slightly Produce effects
8 ?30 The woman The civil servant Severe Slightly Produce effects
9 ?30 The woman The nurse Severe Moderate Effectively
10 ?30 The woman The workman Moderate Slightly Effectively
11 ?33 The woman The coroner Severe Slightly Produce effects
12 ?33 The woman The doctor Severe Slightly Produce effects
13 ?33 The woman The workman Slightly Recovery from illness Recovery from illness
14 ?35 The woman The peasant Slightly Recovery from illness Recovery from illness
15 ?36 The woman The civil servant Moderate Recovery from illness Recovery from illness
16 ?36 The woman The workman Severe Recovery from illness Recovery from illness
17 ?39 The woman The peasant Severe Slightly Produce effects
18 ?39 The woman Accounting Moderate Recovery from illness Effectively
19 ?40 The woman The office worker Severe Moderate Effectively
20 ?40 The woman Unemployed Severe Slightly Produce effects
21 ?42 The woman Unemployed Slightly Recovery from illness Recovery from illness
22 ?42 The woman The civil servant Severe Slightly Produce effects
23 ?42 The woman The nurse Severe Slightly Produce effects
24 ?43 The woman The workman Severe Moderate Effectively
25 ?43 The woman The coroner Moderate Slightly Effectively
26 ?44 The woman The doctor Severe Slightly Produce effects
27 ?44 The woman The workman Severe Slightly Produce effects
28 ?44 The woman The peasant Slightly Recovery from illness Recovery from illness
29 ?46 The woman The civil servant Slightly Recovery from illness Recovery from illness
30 ?46 The woman The civil servant Moderate Recovery from illness Recovery from illness
Result: cure rate 33.3%, obvious effective rate 40%, effective percentage 26.7%.

Claims (5)

1, a kind of eliminating stagnation nodules of the breast plaster, it is characterized in that unguentum comprises Rhizoma Curcumae, Rhizoma Curcumae Longae, Semen Impatientis, Radix Semiaquilegiae, Semen Momordicae, Radix Angelicae Dahuricae Six-element Chinese medicine, the shared parts by weight of each Chinese medicine are respectively: Rhizoma Curcumae 153~187, Rhizoma Curcumae Longae 122~150, Semen Impatientis 122~150, Radix Semiaquilegiae 91.8~112.2, Semen Momordicae 30.6~37.4, the Radix Angelicae Dahuricae 45.9~56.1.
2, eliminating stagnation nodules of the breast plaster according to claim 1 is characterized in that the shared parts by weight of each Chinese medicine are respectively, Rhizoma Curcumae 160, Rhizoma Curcumae Longae 125, Semen Impatientis 125, Radix Semiaquilegiae 95, Semen Momordicae 32, the Radix Angelicae Dahuricae 48.
3, eliminating stagnation nodules of the breast plaster according to claim 1 is characterized in that the shared parts by weight of each Chinese medicine are respectively, Rhizoma Curcumae 170, Rhizoma Curcumae Longae 136, Semen Impatientis 136, Radix Semiaquilegiae 102, Semen Momordicae 34, the Radix Angelicae Dahuricae 51.
4, eliminating stagnation nodules of the breast plaster according to claim 1 is characterized in that the shared parts by weight of each Chinese medicine are respectively, Rhizoma Curcumae 182, Rhizoma Curcumae Longae 145, Semen Impatientis 145, Radix Semiaquilegiae 108, Semen Momordicae 37, the Radix Angelicae Dahuricae 54.
5, a kind of preparation method of eliminating stagnation nodules of the breast plaster is characterized in that a. gets Rhizoma Curcumae, curcuma powder is broken into fine powder, crosses 100 mesh sieves, and is behind 60Co irradiation, standby; B. after getting Semen Impatientis, Radix Semiaquilegiae, Semen Momordicae, Radix Angelicae Dahuricae four Chinese medicine material and being mixed in proportion, be 85% alcohol heating reflux extraction 2 times with accounting for four Chinese medicine gross weight 4 times of amounts, concentration respectively, return time was respectively 1 hour, filter then, it is 1.32 thick paste that merging filtrate, decompression recycling ethanol are concentrated into relative density in the time of 60 ℃, in dry below 60 ℃, be ground into fine powder, cross 100 mesh sieves, standby; Get Mel 1500g, heating dissolves, cross the 180 mesh sieve removal of impurity while hot, the fine powder that in the time of 60 ℃, adds above-mentioned Rhizoma Curcumae and Rhizoma Curcumae Longae, stir, after adding the alcohol extraction cream powder of Semen Impatientis, Radix Semiaquilegiae, Semen Momordicae, the Radix Angelicae Dahuricae four flavor Chinese medicines and concentration again and be 3% laurocapram, stirred 20 minutes, mixing gets final product.
CN 200410043648 2004-06-23 2004-06-23 Ointment for dispersing breast nodules and preparation method thereof Expired - Lifetime CN1251755C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410043648 CN1251755C (en) 2004-06-23 2004-06-23 Ointment for dispersing breast nodules and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410043648 CN1251755C (en) 2004-06-23 2004-06-23 Ointment for dispersing breast nodules and preparation method thereof

Publications (2)

Publication Number Publication Date
CN1593599A true CN1593599A (en) 2005-03-16
CN1251755C CN1251755C (en) 2006-04-19

Family

ID=34665357

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410043648 Expired - Lifetime CN1251755C (en) 2004-06-23 2004-06-23 Ointment for dispersing breast nodules and preparation method thereof

Country Status (1)

Country Link
CN (1) CN1251755C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103394043A (en) * 2013-08-15 2013-11-20 黑龙江鹤翔制药有限责任公司 Application of stasis-removing paste for nodules of breast for treatment of primary dysmenorrheal and ovarian cyst
CN106361960A (en) * 2016-09-30 2017-02-01 上海御贴医药科技有限公司 Traditional Chinese medicine composition capable of treating breast paste and preparation method thereof
CN109260426A (en) * 2018-12-11 2019-01-25 周金 A kind of disease eliminating powder junction pain-stopping external use Chinese medicine and its preparation method and application
CN112791167A (en) * 2021-01-12 2021-05-14 杭州青蜓遵序堂健康管理有限公司 Preparation process of pain-relieving and stasis-removing hydrogel patch

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103394043A (en) * 2013-08-15 2013-11-20 黑龙江鹤翔制药有限责任公司 Application of stasis-removing paste for nodules of breast for treatment of primary dysmenorrheal and ovarian cyst
CN106361960A (en) * 2016-09-30 2017-02-01 上海御贴医药科技有限公司 Traditional Chinese medicine composition capable of treating breast paste and preparation method thereof
CN109260426A (en) * 2018-12-11 2019-01-25 周金 A kind of disease eliminating powder junction pain-stopping external use Chinese medicine and its preparation method and application
CN109260426B (en) * 2018-12-11 2021-08-17 周金 External traditional Chinese medicine for eliminating mass, eliminating stagnation and relieving pain and preparation method and application thereof
CN112791167A (en) * 2021-01-12 2021-05-14 杭州青蜓遵序堂健康管理有限公司 Preparation process of pain-relieving and stasis-removing hydrogel patch

Also Published As

Publication number Publication date
CN1251755C (en) 2006-04-19

Similar Documents

Publication Publication Date Title
CN116392563B (en) Traditional Chinese medicine composition for treating breast nodules as well as preparation and application thereof
CN101176782B (en) Chinese medicine composition for curing galactophore series disease and method of making the same
CN101147798A (en) Galactophore paste and its preparing process
CN1251755C (en) Ointment for dispersing breast nodules and preparation method thereof
CN101040957B (en) Medicine for treating skin diseases such as eczema and dermatitis and the method for preparing the same
CN100369626C (en) Traditional Chinese medicine capsule for treating mammary gland diseases
CN102755563B (en) Traditional Chinese medicine composition for treating chronic prostatitis and preparation method thereof
CN1943691B (en) A Chinese traditional medicinal composition for treatment of osteoporosis and its preparation method
CN102652819B (en) Fuyankang dispersible tablet and preparation method thereof
CN1194724C (en) Chinese medical preparation for treating coronary disease and angina pectoris and preparation thereof
CN1682837A (en) Medicine for regulating blood fat and its preparing method
CN1281228C (en) Medicine for hyperplasia of mammary glands and its preparation
CN1546126A (en) Externally applied medical lotion for treating gynecopathy and its preparing process
CN101554442B (en) Oral blood-clearing preparation
CN101890078B (en) Traditional Chinese medicinal tablets for treating lumbar spinal stenosis and production method thereof
CN100335042C (en) Preparation technology of mammary healthy dispersion tablet
CN1872165A (en) A medicine combination, preparation method and method for controlling quality
CN1137703C (en) Chinese-medicinal ointment for treating mastopathy
CN1299726C (en) Pregnancy promoting pill
CN1131058C (en) Chinese medicine for treating blood viscosity and its preparing process
CN106266152A (en) A kind of pharmaceutical composition treating eczema and its production and use
CN1182856C (en) External medicine for treating mastopathy and its prepn
CN101062260A (en) Granule for complementing Yin and preventing anxiety
CN1404852A (en) Medicine for treating diabetes and its preparation method
CN100500167C (en) Externally applied medicine for treating toothache

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HEILONGJIANG HEXIANG PHARMACEUTICAL CO.

Free format text: FORMER OWNER: QIQIHAR HEXIANG PHARMACEUTICAL CO., LTD.

Effective date: 20061020

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20061020

Address after: 161005 Qigihar city of Heilongjiang Province, the southern suburbs of Longsha District Road No. 3

Patentee after: HEILONGJIANG HEXIANG PHARMACEUTICAL Co.,Ltd.

Address before: 161005 Qigihar city in Heilongjiang Province town in Longsha District Patriotic Village

Patentee before: Qiqihar Hexiang Pharmaceutical Co.,Ltd.

PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Ointment for dispersing breast nodules and preparation method thereof

Effective date of registration: 20130820

Granted publication date: 20060419

Pledgee: Heilongjiang Chen energy Company limited by guarantee

Pledgor: HEILONGJIANG HEXIANG PHARMACEUTICAL Co.,Ltd.

Registration number: 2013230000014

PLDC Enforcement, change and cancellation of contracts on pledge of patent right or utility model
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20140313

Granted publication date: 20060419

Pledgee: Heilongjiang Chen energy Company limited by guarantee

Pledgor: HEILONGJIANG HEXIANG PHARMACEUTICAL Co.,Ltd.

Registration number: 2013230000014

PLDC Enforcement, change and cancellation of contracts on pledge of patent right or utility model
REIN Reinstatement of patent application or patent right
REIN Reinstatement of patent application or patent right
RR01 Reinstatement of patent right

Former decision: cessation of patent right due to non-payment of the annual fee

Former decision publication date: 20150812

CX01 Expiry of patent term

Granted publication date: 20060419

CX01 Expiry of patent term